Blue-chip stocks are from companies that are large, well-established, and financially sound. These companies have strong ...

Pro Medicus shares are trading at a 240% premium to our fair value. Pro Medicus’ strategy revolves around renewing existing ...

Compounders tend to deliver steadier, more durable profit growth across full cycles, making them better suited for long-term ...

Warsh has criticized Powell and advocated for lower interest rates, but analysts are comfortable with his nomination.

We are no longer able to provide Gainers and Losers data for constituents of S&P Australia and NZ indexes. We apologise for any inconvenience. Morningstar Investor clients please sign in here.

Woodside is guiding for a 7%-14% decline in 2026 production to 172-186mmboe, with major second-quarter maintenance for Pluto ...

The bottom line: We raise our fair value estimate for narrow-moat Tesla to $400 from $300. The primary drivers are a higher ...

Coming up: Third-quarter guidance is largely in line with expectations, although it is officially slightly better than our ...

We are no longer able to provide Gainers and Losers data for constituents of S&P Australia and NZ indexes. We apologise for any inconvenience. Morningstar Investor clients please sign in here.

Ray Dalio gives his take on tanking currencies, US mid-term elections and outlook for 2026 and beyond. Investment legend Ray ...

If the tax rate on earnings was 21% instead of 15%, with no overlay Div 296 tax, then the tax on the $70 fully franked ...

The ASX ( ASX: ASX) released unaudited results for the first half of fiscal 2026 and updated near-term expense guidance.